Cambridge Epigenetix
E422483
Cambridge Epigenetix is a biotechnology company specializing in epigenetic sequencing technologies that enable more detailed and cost-effective analysis of DNA modifications for research and clinical applications.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Cambridge Epigenetix canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T4221590 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Cambridge Epigenetix Context triple: [Cambridge life sciences ecosystem, hasKeyCompany, Cambridge Epigenetix]
-
A.
Pacific Biosciences
Pacific Biosciences is a biotechnology company specializing in advanced DNA sequencing technologies, particularly long-read sequencing platforms used in genomics research.
-
B.
Insitro
Insitro is a biotechnology company that uses machine learning and high-throughput biology to accelerate drug discovery and development.
-
C.
Illumina
Illumina is a biotechnology company best known for developing and manufacturing advanced DNA sequencing and array-based technologies used in genomics research and clinical applications.
-
D.
Yale Center for Genomic Health
The Yale Center for Genomic Health is a research and clinical center at Yale focused on advancing precision medicine through genomic analysis, interpretation, and integration into patient care.
-
E.
Eurofins Scientific
Eurofins Scientific is a global leader in bioanalytical testing services, specializing in food, environmental, pharmaceutical, and clinical laboratory analysis.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Cambridge Epigenetix Target entity description: Cambridge Epigenetix is a biotechnology company specializing in epigenetic sequencing technologies that enable more detailed and cost-effective analysis of DNA modifications for research and clinical applications.
-
A.
Pacific Biosciences
Pacific Biosciences is a biotechnology company specializing in advanced DNA sequencing technologies, particularly long-read sequencing platforms used in genomics research.
-
B.
Insitro
Insitro is a biotechnology company that uses machine learning and high-throughput biology to accelerate drug discovery and development.
-
C.
Illumina
Illumina is a biotechnology company best known for developing and manufacturing advanced DNA sequencing and array-based technologies used in genomics research and clinical applications.
-
D.
Yale Center for Genomic Health
The Yale Center for Genomic Health is a research and clinical center at Yale focused on advancing precision medicine through genomic analysis, interpretation, and integration into patient care.
-
E.
Eurofins Scientific
Eurofins Scientific is a global leader in bioanalytical testing services, specializing in food, environmental, pharmaceutical, and clinical laboratory analysis.
- F. None of above. chosen
Statements (41)
| Predicate | Object |
|---|---|
| instanceOf |
biotechnology company
ⓘ
private company ⓘ |
| aimsTo |
enable cost-effective analysis of DNA modifications
ⓘ
enable more detailed analysis of DNA modifications ⓘ |
| contributesTo |
development of epigenetic diagnostics
ⓘ
understanding of epigenetic regulation ⓘ |
| country | United Kingdom ⓘ |
| develops |
library preparation technologies for epigenetic sequencing
ⓘ
methods to detect multiple DNA modifications in a single assay ⓘ |
| field |
epigenetics
ⓘ
epigenomic sequencing ⓘ genomics ⓘ |
| focusesOn |
clinical applications
ⓘ
research applications ⓘ |
| goal |
improve epigenetic data quality
ⓘ
reduce sequencing costs for epigenetic analysis ⓘ |
| hasApplication |
biomedical research
ⓘ
diagnostic development ⓘ precision medicine ⓘ |
| hasFocus |
liquid biopsy applications
ⓘ
non-invasive biomarker discovery ⓘ |
| headquartersLocation | Cambridge, United Kingdom NERFINISHED ⓘ |
| industry |
biotechnology
ⓘ
life sciences ⓘ |
| locatedIn |
Cambridge, England
ⓘ
surface form:
Cambridge
England ⓘ |
| offers |
technologies for analysis of DNA hydroxymethylation
ⓘ
technologies for analysis of DNA methylation ⓘ |
| operatesIn |
epigenetics market
ⓘ
genomics tools market ⓘ |
| serves |
academic researchers
ⓘ
biotechnology companies ⓘ clinical laboratories ⓘ pharmaceutical companies ⓘ |
| specializesIn |
DNA modification analysis
ⓘ
epigenetic sequencing technologies ⓘ |
| subjectOf |
biotech industry reports
ⓘ
epigenomics research news ⓘ |
| technologyType |
epigenetic biomarker detection
ⓘ
next-generation sequencing-based methods ⓘ |
| uses | next-generation sequencing platforms ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Cambridge Epigenetix Description of subject: Cambridge Epigenetix is a biotechnology company specializing in epigenetic sequencing technologies that enable more detailed and cost-effective analysis of DNA modifications for research and clinical applications.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.